Neuralieve, Inc. — Form D
Neuralieve, Inc. of SUNNYVALE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-01-11. The offering totals $7.5M, of which $3.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2010-01-11
- Form: D
- Accession: 0001477913-10-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $7.5M
- Amount sold: $3.9M
- Remaining: $3.6M
- Investors: 24
- Date of first sale: 2009-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-137660
Issuer
- Name: Neuralieve, Inc.
- CIK: 0001477913
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 240 N. WOLFE ROAD, SUNNYVALE, CA, 94085
- Phone: 408-245-6400
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| David Fischell | Director | Eatontown, NJ |
| Robert Fischell | Director | Rutherford, NJ |
| Robert Fischell | Executive Officer | Rutherford, NJ |
| Terese Baker | Executive Officer | San Jose, CA |
| Annette Campbell-White | Director | Framingham, MA |
| Mark Lortz | Director | Sunnyvale, CA |
| Ting Lu | Executive Officer | Sunnyvale, CA |
| Carol Schembri | Executive Officer | Sunnyvale, CA |
| Frank Fisher | Director | Sunnyvale, CA |
Other filings by this issuer (1)
More